Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Guillain-Barre syndrome masquerading as acute respiratory failure in an infant.
More than just multiple sclerosis.
Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
Modulation of a pore in the capsid of JC polyomavirus reduces infectivity and prevents exposure of the minor capsid proteins.
Increased immunopotency of monocyte derived dendritic cells from patients with optic neuritis is inhibited in vitro by simvastatin.
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Epimedium flavonoids ameliorate experimental autoimmune encephalomyelitis in rats by modulating neuroinflammatory and neurotrophic responses.
Atorvastatin: Multiple Sclerosis.
The relationship between total and regional corpus callosum atrophy, cognitive impairment and fatigue in multiple sclerosis patients.
Quantitative susceptibility mapping (QSM): Decoding MRI data for a tissue magnetic biomarker.
Who receives rehabilitation in canadian long-term care facilities? A cross-sectional study.
Management of Secondary Progressive Multiple Sclerosis: Prophylactic Treatment-Past, Present, and Future Aspects.
The impact of osteopontin gene variations on multiple sclerosis development and progression.
Anorectal dysfunction in multiple sclerosis: a systematic review.
Coincidence of spinal tumor (astrocytoma) and non-specific encephalomyelitis.
Optical Coherence Tomography versus Visual Evoked Potentials in detecting subclinical visual impairment in multiple sclerosis.
The complement cascade: Yin-Yang in neuroinflammation--neuro-protection and -degeneration.
CENTENARIAN RATES AND LIFE EXPECTANCY RELATED TO THE DEATH RATES OF MULTIPLE SCLEROSIS, ASTHMA AND RHEUMATOID ARTHRITIS AND THE INCIDENCE OF TYPE 1 DIABETES IN CHILDREN.
Accurate determination of blood-brain barrier permeability using dynamic contrast-enhanced T1-weighted MRI: a simulation and in vivo study on healthy subjects and multiple sclerosis patients.
Diffusion tensor imaging in the human spinal cord: development, limitations, and clinical applications.
Sodium channels in astroglia and microglia.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.
Alemtuzumab (LEMTRADA) and multiple sclerosis. Biased evaluation, evidence of serious risks.
Pages
« first
‹ previous
…
256
257
258
259
260
261
262
263
264
…
next ›
last »